LNTH News and Press, Lantheus Holdings Inc. From 02/25/22

Gainers: Aerie Pharmaceuticals (NASDAQ:AERI) +25%. Schrodinger (NASDAQ:SDGR) +17%. MDxHealth (NASDAQ:MDXH) +16%. Lantheus (NASDAQ:LNTH) +13%. Tabula Rasa HealthCare (NASDAQ:TRHC) +13%. Losers: Baudax Bio BXRX -55%. The Joint (NASDAQ:JYNT) -15%. Biohaven...

Russia's invasion of Ukraine triggered a volatile session on Wall Street, with the major averages recovering from an early selling spree to finish Thursday's trading with gains. With tech stocks leading both the initial selling and the late recovery, the Nasdaq went full circle, turning an ea...

Lantheus Holdings (NASDAQ: LNTH) had one of the best days of its life on the stock exchange Thursday. The specialty healthcare company saw its shares blast more than 39% higher on the strength of its latest earnings report, published that morning. For its Q4 of 2021, Lantheus ea...

Gainers: Indonesia Energy Corporation (NYSE:INDO) +65%. Camber Energy (NYSE:CEI) +40%. South Jersey Industries (NYSE:SJI) +40%. Post Holdings (NYSE:POST) +34%. Lantheus Holdings (NASDAQ:LNTH) +33%. Imperial Petroleum (NASDAQ:IMPP) +30%. Cyren (NASDAQ:CYRN) +28%. TransMedics Group (NASDAQ:TMDX...

Lantheus Holdings, Inc. (LNTH) Q4 2021 Earnings Conference Call February 24, 2022, 8:00 AM ET Company Participants Mary Anne Heino – President and Chief Executive Officer Mark Kinarney – Senior Director of Investor Relations Paul Blanchfield – Chief Commercial Officer Rob...

Gainers: Lantheus (NASDAQ:LNTH) +34%. Evolent Health (NYSE:EVH) +18%. Clover Health (NASDAQ:CLOV) +10%. Liquidia (NASDAQ:LQDA) +10%. iRhythm Technologies (NASDAQ:IRTC) +8%. Losers: Orphazyme (NASDAQ:ORPH) -36%. Rhythm Pharmaceuticals (NASDAQ:RYTM) -24%. Tabu...

Healthcare supplier Lantheus Holdings (NASDAQ:LNTH) has added ~32% in the pre-market Thursday on above-average volume after the company set its outlook ahead of Wall Street forecasts on the back of a strong beat in its Q4 2021 financials. Worldwide revenue for the quarter and f...

Partnership leverages Palette’s specialty sales team to increase promotional footprint of PYLARIFY within the urology call point SANTA BARBARA, Calif. and STOCKHOLM, Sweden, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Palette Life Sciences (“Palette”), a global medical de...

Lantheus press release (NASDAQ:LNTH): Q4 Non-GAAP EPS of $0.25 beats by $0.08. Revenue of $129.6M (+37.6% Y/Y) beats by $17.83M. For further details see: Lantheus Non-GAAP EPS of $0.25 beats by $0.08, revenue of $129.6M beats by $17.83M

Worldwide revenue of $129.6 million and $425.2 million for the fourth quarter and full year 2021, representing an increase of 37.6% and an increase of 25.3% over the prior year period, respectively GAAP net loss of $40.2 million and $71.3 million for the fourth quarter and full ...